The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation

Experimental Cell Research

Volumn 256, Issue 1, 2000, Pages 158-167

  Lemonnier, J ^a   Delannoy, Ph ^a   Hott, M ^a   Lomri, A ^a   Modrowski, D ^a   Marie, P J ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Differentiation; Downregulation; FGFR 2 mutation; Osteoblasts; Signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN KINASE C;

ACROCEPHALOSYNDACTYLY; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; FETUS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 0034630504     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4820     Document Type: Article

References (49)

1. Pritchard J. J., Scott J. H., Girgis F. G. The structure and development of cranial and facial sutures. J. Anat. 90:1993;73-86.
2. Persson M., Magnusson B. C., Thilander B. Sutural closure in rabbit and man: A morphological and histochemical study. J. Anat. 125:1978;313-321.
3. Decker J. D., Hall S. H. Light and electron microscopy of the new born sagittal suture. Anat. Rec. 212:1985;81-89.
4. Cohen M. M. Transforming growth factor βs and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12:1997;322-330.
5. Iseki S., Wilkie A. O. M., Heath J. K., Ishimura T., Eto K., Morriss-Kay G. M. FGFR-2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development. 124:1997;3375-3384.
6. Kim H.-J., Rice D. P. C., Kettunen P. J., Thesleff I. FGF-, BMP- and Shh-mediated signaling pathways in the regulation of cranial suture morphogenesis and calvaria bone development. Development. 125:1998;1241-1251.
7. Most D., Levine J. P., Chang J., Sung J., McCarthy J. G., Schendel S. A., Longaker M. T. Studies in cranial suture biology: Up-regulation of transforming growth factor-β1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101:1998;1431-1440.
8. Givol D., Yahon A. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J. 6:1992;3362-3369.
9. Jaye M., Schlessinger J., Dionne C. A. Fibroblast growth factor receptor kinases: Molecular analysis and signal transduction. Biochem. Biophys. Acta. 1135:1992;185-199.
10. Wang J. K., Gao G., Goldfarb M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14:1994;181-188.
11. Newton A. C. Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 270:1995;28495-28498.
12. Sanders J. L., Stern P. H. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts. J. Bone Miner. Res. 11:1996;1862-1872.
13. Muenke M., Schelle U. Fibroblast growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11:1995;308-313.
14. Wilkie A. O. M., Morriss-Kayn G. M., Jones E. Y., Heath J. K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5:1995;500-507.
15. Webster M. K., Donoghue D. J. FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet. 13:1997;178-182.
16. Burke D., Wilkes D., Blundell T. L., Malcom S. Fibroblast growth factor receptors: Lessons from the genes. TIBS. 23:1998;59-62.
17. Park W. J., Theda C., Maestri N. E., Meyers G. A., Fryburg J. S., Dufresne C., Cohen M. M. Analysis of phenotypic features and FGFR-2 mutations in Apert syndrome. Am. J. Hum. Genet. 57:1995;321-328.
18. Wilkie A. O. M., Slaney S. F., Oldridge M., Poole M. D., Asworth G. J., Hockley A. D., Hayward R. D., David D., Pulleyn L. J., Rutland P., Malcom S., Winter R. M., Reardon W. Apert syndrome results from localized mutations of FGFR-2 and is allelic with Crouzon syndrome. Nature Genet. 9:1995;165-172.
19. Neilson K. M., Friesel R. E. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270:1995;26037-26040.
20. Galvin B. D., Hart K. C., Meyer A. N., Webster M. K., Donoghue D. J. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR-2 and FGFR-2/Neu chimeras). Proc. Natl. Acad. Sci. USA. 93:1996;7894-7899.
21. Anderson J., Burns H. D., Enriquez-Harris P., Wilkie A. O. M., Heath J. K. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Genet. 7:1998;1475-1483.
22. Lomri A., Lemonnier J., Hott M., de Perseval N., Lajeunie E., Munnich A., Renier D., Marie P. J. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor-2 mutations in Apert syndrome. J. Clin. Invest. 101:1998;1310-1317.
23. De Pollak C., Arnaud E., Renier D., Marie P. J. Age-related changes in bone formation, osteoblastic cell proliferation and differentiation during postnatal osteogenesis in human calvaria. J. Cell. Biochem. 64:1997;128-139.
24. De Pollak C., Renier D., Hott M., Marie P. J. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J. Bone Miner. Res. 11:1996;401-407.
25. Baron R., Vignery A., Neff L., Silverglate A., Maria A. S. Processings of undecalcified bone specimens for bone histomorphometry. Recker R. R. Bone Histomorphometry. 1983;13-36 CRC Press, Boca Raton.
26. van Dierendonck J. H., Wijsman J. H., Keijzer R., van de Velde C. J., Cornelisse C. J. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am. J. Pathol. 138:1991;1165-1172.
27. Machwate M., Jullienne A., Moukhtar M., Marie P. J. Temporal variation of c-fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J. Cell. Biochem. 57:1995;62-70.
28. Aubin J. E., Liu F. The osteoblast lineage. Bilezikian J. P., Raisz L. G., Rodan G. A. Principles of Bone Biology. 1996;51-68 Academic Press, San Diego.
29. Marie P. J. Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histol. Histopathol. 14:1999;525-539.
30. Fisher L. W., Stubbs J. T. III, Young M. F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Othop. Scand. 66:1995;61-65.
31. Tamaoki T., Nakano H. Potent and specific inhibitors of protein kinase C of microbial origin. Biotechnology. 8:1990;732-735.
32. Alessi D. R., Cuenda P., Cohen D. T., Dudley D. T., Satiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27499.
33. Kramer R. M., Roberts E. F., Um S. L., Borsh-Haubold A. G., Watson S. P., Fisher M. J., Jakubowski J. A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271:1996;27723-27729.
34. Delezoide A. L., Benoist-Lasselin C., Legeai-Mallet L., Le Merrer M., Munnich A., Vekemans M., Bonaventure J. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev. 77:1998;19-30.
35. Bresnick S., Schendel S. Crouzon's disease correlates with low fibroblast growth factor receptor activity in stenosed cranial sutures. J. Craniofac. Surg. 6:1995;245-250.
36. Neufeld G., Gospodarowicz D. The identification and partial characterization of the fibroblast growth factor of baby hamster kidney cells. J. Biol. Chem. 260:1985;13860-13868.
37. Rizzino A., Kazakoff P., Ruff E., Kuszynski C., Nebelsick J. Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. Cancer Res. 48:1988;4266-4271.
38. Moscatelli D. Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells. J. Cell Physiol. 160:1994;555-562.
39. Estival A., Monzat V., Miquel K., Gaubert F., Hollande E., Korc M., Vaysse N., Clemente F. Differential regulation of fibroblast growth factor (FGF) receptors mRNA and protein by two molecular forms of basic FGF: Modulation of FGFR-1 mRNA stability. J. Biol. Chem. 271:1996;5663-5666.
40. Armstrong E., Vainikka S., Partanan J., Korhonen J., Alitalo R. Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res. 52:1992;2004-2008.
41. Asakai R., Akita Y., Tamura K., Kenmotsu N., Aoyama Y. Protein kinase-C dependent down-regulation of basic growth factor (FGF-2) receptor by phorbol ester and epidermal growth factor in porcine granulosa cells. Endocrinology. 136:1995;3470-3479.
42. Hurley M. M., Florkiewitz R. Z. Fibroblast growth factor and vascular endothelial fibroblast growth factor families. Bilezikian J. P., Raisz L. G., Rodan G. A. Principles of Bone Biology. 1996;627-646 Academic Press, San Diego.
43. Rapraeger A. C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr. Opin. Cell Biol. 5:1993;844-853.
44. Liuzzo J. P., Moscatelli D. Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: Downmodulation of FGF receptors by phorbol ester. Blood. 87:1996;245-255.
45. Sorokin A., Mohammadi M., Huang J., Schlessinger J. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J. Biol. Chem. 269:1994;17056-17061.
46. Mehara B. J., Mackool R. J., McCarthy J. G., Gittes G. K., Longaker M. T. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102:1998;1805-1820.
47. Iseki S., Wilkie A. O. M., Morris-Kay G. M. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development. 126:1999;5611-5620.
48. Molténi A., Modrowski D., Hott M., Marie P. J. Differential expression of fibroblast growth factor receptors-1, -2 and -3 and syndecans-1, -2 and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone. 24:1999;337-347.
49. Marie P. J., Lomri A., Debiais F., Lemonnier J. Fibroblast growth factors and osteogenesis. Canalis E. Skeletal Growth Factors. 2000;Lippincott Williams & Wilkins, Baltimore.